PDC Line Pharma Competitors and Similar CompaniesClear all

PDC Line Pharma's competitors and similar companies include Harbour Antibodies, GrayBug, Rebiotix and PellePharm.

	PDC Line Pharma PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens.	Harbour Antibodies Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.	GrayBug GrayBug is a biotechnology company developing technologies to treat eye diseases.	Rebiotix Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.	PellePharm PellePharm, Inc. operates in the biotechnology industry.
Founding Date	Founding Date 2014	Founding Date 2006	Founding Date 2011	Founding Date 2011	Founding Date 2012
Type	Type Private	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare Technology biotech healthtech	Tags Healthcare Technology biotech healthtech	Tags Healthcare Technology biotech healthtech	Tags Healthcare Technology biotech healthtech	Tags Healthcare Technology biotech healthtech
Locations	Locations La Tronche, FR HQ Liège, BE	Locations Newton, US HQ	Locations Redwood City, US HQ Baltimore, US	Locations Saint Paul, US HQ	Locations San Francisco, US HQ
Employees	Employees 375% decrease	Employees 1	Employees 4	Employees 70	Employees 5
Funding
Latest funding round	Latest funding round $ 22.2m (over 6 years ago)	Latest funding round $ 3.2m (almost 13 years ago)	Latest funding round $ 80m (almost 7 years ago)	Latest funding round $ 25m (almost 12 years ago)	Latest funding round $ 70m (over 7 years ago)
Total funding raised	Total funding raised $ 26.5m	Total funding raised $ 3.2m	Total funding raised $ 128.5m	Total funding raised $ 27.8m	Total funding raised $ 81.4m